Upregulation of CXCR1 by proliferating cells in patients with lymphoproliferative disease of granular lymphocytes.
The expression and the functional activities of different chemokine receptors (CC motif: CCR1, CCR2, CCR3, CCR5, CCR6; CXC motif: CXCR1, CXCR2, CXCR3, CXCR4, CXCR5) were investigated in 12 patients with lymphoproliferative disease of granular lymphocytes (LDGL). Six patients were characterized by the proliferation of CD3+ve GL and six patients by the expansion of CD3-ve GL. The interleukin 8 (IL-8/CXCL8) receptor CXCR1 was expressed in 12/12 patients, the CXCR4 in 6/12 patients (four CD3+ve and two CD3-ve) and the CXCR3 in 3/12 patients (one CD3+ve and two CD3-ve). CXCR1 was expressed only by proliferating GL. Other CC and CXC receptors were not expressed on proliferating GL (< 2%). In functional assays, purified GL from the patients displayed significant migration in response to specific chemokines, indicating that CXCR1, CXCR3 and CXCR4 were functionally active in these patients. In addition, a significant reduction of IL-8/CXCL8-mediated cell migration was reported in the presence of anti-CXCR1 monoclonal antibody. Our results indicate that expanding cells from patients with LDGL express specific CXCR. These data may help to define functional properties of proliferating GL in patients with LDGL and contribute toward the understanding of the complex clinical features of this disease. In particular, as CXCR1 was expressed in all of the patients studied, we speculate that abnormal expression of this receptor on proliferating GL might play a role in the pathogenesis of neutropenia, which represents a common feature in LDGL patients.
Zambello
Renato
R
Padova University School of Medicine, Department of Clinical and Experimental Medicine, Clinical Immunology Branch, Padova, Italy.
Trentin
Livio
L
Facco
Monica
M
Carollo
Davide
D
Cabrelle
Anna
A
Tosoni
Alicia
A
Cannas
Giovanna
G
Nicolardi
Linda
L
Agostini
Carlo
C
Semenzato
Gianpietro
G
D002455:Cell Division; D002464:Cell Migration Inhibition; D005260:Female; D006098:Granulocytes / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D016209:Interleukin-8 / Q000378:metabolism*; D008232:Lymphoproliferative Disorders / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D012333:RNA, Messenger / Q000378:metabolism; D023062:Receptors, Interleukin-8A / Q000378:metabolism*; D015854:Up-Regulation
D016209:Interleukin-8; D012333:RNA, Messenger; D023062:Receptors, Interleukin-8A